The CSIBD Enrichment Program has a history of facilitating the exchange of information between affiliated institutions.
The CSIBD and the Center for Microbiome Informatics and Therapeutics (CMIT) hold joint Work-In-Progress meetings that focus heavily on the work of graduate students and postdoctoral fellows.
February 27, 2020
Suhyun Kim, Ph.D. (Silver Group, Harvard Medical School)
Beyond Antibiotics: Learning from Nature in Designing Therapeutic Bacteria to Specifically Target Pathogens
January 23, 2020
Daniel Graham, Ph.D., Damian Plichta, Ph.D., and Eric Brown, Ph.D. (Graham Group, Broad Institute)
Antigen Discovery: A View of the Microbiome Through the Lens of a T cell
January 9, 2020
Christine Isabella (Kiessling Group, MIT)
Lectins as Microbial Detectors
Work-In-Progress Meetings in Previous Years
June 13, 2019
Shijie Zhao (Alm Group, MIT)
Evolutionary dynamics of commensal microbiome in health and disease across human populations
June 6, 2019
Lauren Rajakovich, PhD, and Yindi Jiang, PhD (Balskus Group, Harvard University)
Understanding and Harnessing Gut Microbiome-Small Molecule Interactions
May 9, 2019
Mathieu Groussin, PhD (Alm Group and Global Microbiome Conservancy)
Impact of industrialization on the human gut microbiome
April 11, 2019
Craig McLean (Kujawinski Group, Woods Hole Oceanographic Institution)
Improved informatics contribute to the characterization of metabolism in non-model organism through untargeted metabolomics
February 14, 2019
Siyuan Ma (Huttenhower Group, Harvard School of Public Health)
Meta-Analysis of Population Structure in the IBD Gut Microbiome
January 24, 2019
Amanda Dugan, PhD (Kiessling Group, MIT)
Microbial recognition properties of human lectins
December 20, 2018
Alexander Naydich (Silver Group, Harvard Medical School)
Engineering commensal gut bacteria for biomarker discovery
November 29, 2018
Daniel Graham, PhD (Xavier Group, Broad Institute)
Antigen Discovery: A View of the Microbiome Through the Lens of a T cell
October 4, 2018
Kelsey Wheeler (Ribbeck Group, MIT)
Probing microbial interactions with the mucus barrier
September 13, 2018
Ari Adhikari, PhD (Devlin Group, Harvard Medical School)
Targeting gut bacterial bile salt hydrolases for therapeutic applications
June 11, 2018
Siyuan Ma, PhD (Huttenhower Group, Harvard School of Public Health)
Meta-Analysis of Population Structure in the IBD Gut Microbiome
May 10, 2018
Kate Jeffrey, PhD (Massachusetts General Hospital)
Defining the immunomodulatory capacity of the intestinal virome
May 4, 2018
Sumaiya Nazeen, PhD (Berger Group, MIT)
Towards improved discovery of functional dysbiosis in patient microbiomes: Alignment-free functional binning of metagenomic reads
April 12, 2018
Larson Hogstrom and Moran Yassour, PhD (Xavier and Lander Groups, Broad Institute)
Early life mother-to-child microbial transmission
March 2, 2018
Michael J. Fink, PhD (Whitesides Group, Harvard University)
How to separate mixtures of bacteria?
Christoffer Karl Abrahamsson, PhD (Whitesides Group, Harvard University)
MagLev for Density Measurements and Separation in Biology (C.K.A.)
January 11, 2018
Sean Kearney, PhD (Alm Group, MIT)
Principles for engineering niche space in the human gut microbiota
Le Thanh Tu Nguyen (Alm Group, MIT)
Functional heterogeneity of prebiotic fermentation capabilities in healthy humans (LTTN)
December 14, 2017
Yindi Jiang, PhD, and Carina Chittim, PhD (Balskus Group, Harvard University)
Understanding and Harnessing Gut Microbiome-Small Molecule Interactions
December 1 2017
Sloan Devlin, PhD (Harvard Medical School)
In vivo control of gut bacterial bile acid metabolism
November 17, 2017
Melissa Takahashi, PhD, Nicolaas Manuel Angenent-Mari, PhD, & Shimyn Slomovic, PhD (Collins Group, MIT)
Synthetic Biology Diagnostics for the Gut Microbiome
November 9, 2017
Arlene Sharpe, MD, PhD (Harvard Medical School)
Defining the Crosstalk between the PD-1 Pathway and the Microbiome
September 14, 2017
Katharina Ribbeck, PhD (MIT)
Probing microbial interactions with the mucus barrier
August 10, 2017
Mohit Verma, PhD (Whitesides Group, Harvard)
Butyrate: a link Between Us and Our Microbiome
August 4, 2017
Doug Kenny (Xavier Group, Broad Institute)
Activity-guided discovery of small molecules from the gut microbiota
Brantley Hall, PhD (Xavier Group, Broad Institute)
A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients
June 30, 2017
Siyuan Ma, PhD (Huttenhower Group, Harvard T.H. Chan School of Public Health)
Meta-Analysis of Population Heterogeneity in IBD Patients' Gut Microbiome
June 8, 2017
Mark Mimee, PhD, Isaak Mueller, PhD, and Cheng Chang, PhD (Lu Group, MIT)
Engineering Probiotics as Diagnostics and Therapeutics
June 2, 2017
William Yu, PhD (Berger Group, MIT)
Compressive Metagenomics: Scaling Faster than Light
March 9, 2017
Kathryn Kauffman, PhD (Polz Group, MIT)
Ecology of Bacterial Viruses in the Human Microbiome
February 23, 2017
Jason Lloyd-Price, PhD (Huttenhower Group, Harvard T. H. Chan School of Public Health)
Expanding the NIH Human Microbiome Project: Metagenomics, functions, strains, and dynamics of the healthy microbiome
January 12, 2017
Nitzan Koppel, PhD, Vayu Maini Rekdal, PhD, and Yindi Jiang, PhD (Balskus Group, Harvard)
Understanding and harnessing microbiome-drug interactions
December 8, 2016
Moshe Biton, PhD, Rebecca Herbst, MSc, & Jose Ordovas-Montanes, PhD (Shalek Group, MIT & Regev Group, Broad Institute)
Single-Cell Genomic Approaches for Understanding the Human Gut
September 8, 2016
Angelina Bilate, PhD (Ploegh Group, Whitehead Institute)
Microbiota-dependent differentiation of intestinal regulatory T cells and intraepithelial lymphocytes from a clonal T-cell precursor
August 11, 2016
Dana Braff, PhD, Melissa Takahashi, PhD, and Xiao Tan, MD, PhD (Collins Group, MIT)
Paper-based Diagnostics for IBD
June 9, 2016
Phil Arevalo, PhD (Polz Group, MIT)
A biological definition of microbial populations and its application to a reverse ecology approach
May 12, 2016
Nathaniel Roquet, PhD (Lu Group, MIT)
Engineering synthetic state machines in living cells
April 14, 2016
Melanie Schirmer, PhD (Xavier Group, Broad Institute)
Interactions of the gut microbiome and the inflammatory cytokine response in healthy individuals
Aleksander Kostic, PhD (Xavier Group, Broad Institute)
Exploring Biosynthetic Gene Clusters Associated with Inflammatory Bowel Disease
March 10, 2016
William Yu, PhD (Berger Group, MIT)
Compressive algorithms: trade-offs in runtime, memory, and storage
February 11, 2016
Moshe Biton, PhD, & Adam Haber, PhD (Regev Group, Broad Institute)
Dissecting gut epithelial tissue to uncover novel cell state and function
January 14, 2016
Eric Alm, PhD (MIT)
Microbiome based medicine: from genomics to diagnostics and therapeutics
October 15, 2015
Jim Collins, PhD (MIT)
Paper-based Diagnostics for IBD
October 1, 2015
Timothy Lu, MD, PhD (MIT)
Synthetic Microbes as Next Generation Ulcerative Colitis Diagnostics and Treatments